DMEPOS Supplier Accreditation Consulting — Integral Healthcare Solutions

Last updated: April 2026

CMS requires every DMEPOS supplier billing Medicare to hold active accreditation from a CMS-approved organization. IHS guides suppliers from gap assessment through accreditation award and Medicare enrollment — with independent, accreditor-neutral expertise no competitor can match.

IHS is the only URAC-certified accreditation consulting firm in the United States. Our principal, Thomas G. Goddard, JD, PhD, brings legal, regulatory, and clinical systems expertise to every DMEPOS engagement.

Schedule a Gap Analysis | DMEPOS Accreditation FAQ | Cost Guide

What Is DMEPOS Supplier Accreditation?

DMEPOS supplier accreditation is mandatory CMS certification that proves your organization meets the quality standards required to bill Medicare for durable medical equipment, prosthetics, orthotics, and supplies. Every one of the approximately 8,005 active traditional Medicare DMEPOS supplier locations in the United States holds CMS-recognized accreditation — it is a non-negotiable condition of Medicare enrollment, not an optional credential.

DMEPOS stands for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies — a category covering hospital beds, wheelchairs, respiratory equipment, orthotic braces, diabetic testing supplies, enteral nutrition, continuous glucose monitors (CGMs), and more. Any organization billing Medicare for items in these categories must be accredited by one of the 9 CMS-approved accrediting organizations (AOs) as of early 2026.

Accreditation confers "deemed status" — meaning the accrediting organization has verified on CMS's behalf that your operations meet the CMS DMEPOS Supplier Quality Standards. Without active accreditation, Medicare claims are rejected and civil monetary penalties exceeding $25,000 apply to any billing attempted while unaccredited.

Who Needs DMEPOS Accreditation?

Any organization billing Medicare for covered DMEPOS items needs CMS-recognized accreditation, including:

Traditional HME/DME suppliers (mobility devices, hospital beds, respiratory equipment)
Community, long-term care, and specialty pharmacies billing for diabetic testing supplies, enteral nutrition, or off-the-shelf (OTS) orthotics
Orthotics and Prosthetics (O&P) clinics, chiropractors, physical therapists, and dental sleep medicine practices providing oral appliances for sleep apnea
Retailers and e-commerce platforms distributing CGMs, orthotic braces, or telehealth-coordinated DMEPOS across state lines
M&A acquirers in the DMEPOS sector requiring due diligence under the 36-month ownership transfer rule

The 9 CMS-Approved Accrediting Organizations

Nine organizations hold CMS approval to accredit DMEPOS suppliers as of early 2026: ACHC, The Compliance Team (TCT), Board of Certification/Accreditation (BOC — reinstated under Temporary Restraining Order January 9, 2026, with CA/FL/NY/TX regional restrictions), ABC (American Board for Certification in O&P/Pedorthics), CHAP, The Joint Commission (TJC), HQAA, NABP, and DNV Healthcare. IHS works across all nine and provides independent guidance on accreditor selection with no financial relationship with any AO.

2026 DMEPOS Regulatory Shockwave — What Changed and What It Means

Three regulatory changes effective January 1, 2026 fundamentally restructured DMEPOS compliance. The business model has permanently shifted from triennial accreditation projects to continuous annual compliance programs.

Annual Survey Mandate — From 36 Months to 12 Months

Effective January 1, 2026, CMS requires every accredited DMEPOS supplier to be resurveyed at least once every 12 months. Previously, surveys occurred every 36 months. This change tripled annual survey volume nationwide and eliminated ad hoc preparation as a viable strategy. Organizations that were prepared once every three years must now maintain continuous readiness 365 days a year.

The operational implication: suppliers with more than $2 million in annual Medicare billing now require 0.5 to 1.0 dedicated FTE focused on Quality Assurance and Performance Improvement (QAPI). This compliance officer manages continuous lot tracking, peer review audits, staff competency assessments, and complaint logs on an ongoing basis. The cost of under-staffing is an 18-month Medicare billing suspension upon survey failure.

36-Month Ownership Transfer Rule

The 36-month rule now applies to DMEPOS: any change in majority ownership (greater than 50%) within 36 months of enrollment or the last ownership change triggers immediate Medicare billing termination and mandatory new enrollment. For M&A transactions, this rule creates deal-structuring complexity that requires specialized accreditation and regulatory counsel. Compounding this, a 6-month nationwide moratorium on new Medicare enrollments for DMEPOS medical supply companies took effect February 27, 2026 — trapping M&A activity requiring new enrollment.

Elimination of the 90-Day Temporary Billing Grace Period

The 90-day temporary billing authorization for new DMEPOS branch locations was eliminated effective January 1, 2026. Every new physical location must now be fully surveyed and accredited before billing a single Medicare claim. Expansion plans that previously took advantage of temporary billing authority require complete upfront accreditation investment.

The DMEPOS Accreditation Process — Step by Step

DMEPOS accreditation takes 4 to 8 months from non-compliant baseline to accreditation award. Post-accreditation PECOS Medicare enrollment adds 50 to 180 additional calendar days. Here is what IHS does at each phase:

Phase 1: Gap Assessment and Baseline Audit (Weeks 1–3)

IHS conducts a comprehensive review of your physical operations, documentation systems, and staff records against CMS Quality Standards and the specific accrediting organization's manual. We identify critical vulnerabilities before they become survey citations. Most organizations have significant documentation gaps before they know to look for them — 60% of failed surveys cite documentation errors as the primary cause, not clinical negligence.

Phase 2: Policy and Procedure Development (Weeks 4–8)

IHS develops customized policies and procedures for your specific product categories and operational footprint. Required documentation includes TB control plans with verified personnel screening records, equipment cleaning and separation protocols, corporate compliance frameworks, patient rights documentation, grievance procedures, and annual leadership policy review processes. Generic templates fail surveys. Your documentation must match your actual operations.

Phase 3: Implementation and Staff Training (Weeks 9–12)

IHS trains your staff on HIPAA, Fraud Waste and Abuse (FWA), patient equipment instruction, OSHA protocols, and infection control — and generates the compliant training documentation logs that prove it happened. The ACHC Equipment Cleaning and Storage standard (DRX7-12D) is cited in 30% of ACHC surveys for the fifth consecutive year. Physical separation of clean and dirty equipment, warehouse sanitation, and transport protocols must be drilled into operations, not just documented.

Phase 4: Mock Survey and Tracer Exercises (Weeks 13–14)

IHS conducts an unannounced simulated survey with aggressive staff interviews and a full warehouse facility inspection — mirroring actual surveyor methodology. We identify remaining gaps before you pay a non-refundable application deposit. Tracer exercises simulate how a real surveyor follows a patient file from intake through delivery, exposing process breakdowns invisible on paper.

Phase 5: Application Submission and Live Survey (Weeks 15–20+)

IHS manages application submission to your chosen AO, including the non-refundable deposit and all supporting documentation. The AO dispatches a surveyor for an unannounced on-site visit. IHS is available throughout to support staff and respond to surveyor requests. ACHC base survey fees run $2,000–$7,000+; ABC first-time applicant fees are $1,855 for primary location plus $965 per affiliate location. The $750 CMS enrollment application fee applies separately.

Phase 6: Plan of Correction and PECOS Enrollment (Weeks 20–30+)

If the surveyor cites deficiencies, IHS prepares your Plan of Correction (CAP) response within the required submission timeline. After accreditation award, IHS supports your CMS-855S submission through PECOS to Novitas Solutions (East) or Palmetto GBA (West). The federal mandate is 50 calendar days for online PECOS processing, but Novitas administrative backlogs frequently run 3 to 6 months in practice. IHS monitors your application status and escalates when processing stalls.

Most Common DMEPOS Survey Deficiencies

Documentation errors drive 60% of DMEPOS survey failures. The deficiencies below are what IHS specifically targets during gap assessment and mock survey — these are not theoretical risks, they are the actual citation leaders from ACHC, TCT, CHAP, and CMS surveys in 2025–2026.

Equipment Cleaning and Storage (ACHC DRX7-12D) — Physical separation of clean and dirty equipment, inadequate infection control during transport, poor warehouse sanitation. Cited in 30% of ACHC surveys for the fifth consecutive year. (Source: ACHC 2025 [citation needed])
Safety Program Documentation — Outdated safety policies, inadequate oxygen tank storage procedures, missing PPE protocols, fire safety compliance failures. (Source: CHAP 2025/2026)
Tuberculosis (TB) Control Plans — Failure to audit and maintain personnel records confirming required TB screenings per state and CDC guidelines prior to patient contact. (Source: CHAP 2025/2026)
Leadership Policy Review (TCT ADM 1.0) — No documented evidence that organizational leadership formally reviewed the P&P manual and operational forms on an annual basis. (Source: TCT 2025/2026)
Ongoing HR Training (TCT HR 1.0) — Failure to document annual post-hire training on Corporate Compliance, FWA, HIPAA, and OSHA standards. (Source: TCT 2025/2026)
Patient Equipment Training — Missing signed documentation proving patients and caregivers received and understood equipment use instructions. (Source: CHAP 2025/2026)
Respiratory Setup Guidelines — Failure to align clinical respiratory setups with current American Association for Respiratory Care (AARC) guidelines. (Source: CHAP 2025/2026)
Patient File Credentialing — Missing physician signatures, absent date stamps, or missing face-to-face encounter notes prior to delivery. CMS now requires F2F encounters for 83 DMEPOS items as of April 13, 2026. (Source: CMS)
Complaint Log Management — Failure to maintain a distinct, accessible log of patient complaints and subsequent internal resolutions. (Source: CMS)
Sanitary Environment — General facility cleanliness failures, specifically in complex rehab modification areas or CPAP mask fitting rooms. (Source: ACHC)

State-Specific Requirements Beyond Federal Accreditation

Federal accreditation is the floor, not the ceiling. Several states impose additional licensing requirements that out-of-state DMEPOS suppliers must satisfy before operating. IHS maps your state exposure and manages both the federal and state compliance tracks simultaneously.

Florida — Requires an in-state registered agent, local site inspection, and a surety bond exceeding $50,000. Also subject to BOC regional restrictions.
Texas — Requires foreign entity registration and a Device Distributor License through the Texas Department of State Health Services (DSHS). Also subject to BOC regional restrictions.
California — Requires HMDR (Home Medical Device Retailer) licensing at approximately $1,509 in annual base fees. Also subject to BOC regional restrictions.
Illinois — Requires a 10–12 week regulatory process and a bond of $10,000–$50,000 for out-of-state suppliers.
New York / Nevada / Arizona — Rely on baseline federal accreditation without standalone state DME licenses, though BOC regional restrictions apply in New York.

What Does DMEPOS Accreditation Cost?

Full accreditation preparation for a single location costs $4,500–$18,000+ in consulting fees, plus $2,000–$7,000+ in AO survey fees and the $750 CMS enrollment application fee. Annual retainer engagements for continuous readiness under the new 12-month survey cycle run $1,000–$5,000 per year. See our DMEPOS Accreditation Cost Guide for a complete fee-by-fee breakdown.

The cost of failure is substantially higher: an 18-month Medicare billing suspension plus civil monetary penalties exceeding $25,000. For a supplier with $5 million in annual Medicare revenue, an 18-month suspension represents more than $7 million in lost revenue — against which a $15,000 consulting engagement is routine risk management.

The 2028 Competitive Bidding Program bid window opens Late Summer/Early Fall 2026. Only accredited suppliers may submit bids. CMS projects awarding approximately 10 national contracts for CGMs and insulin pumps. Failing accreditation in 2026 locks a supplier out of CBP until the next round — which may be the better part of a decade away.

Why IHS for DMEPOS Accreditation Consulting

IHS is the only URAC-certified accreditation consulting firm in the United States. That credential is not cosmetic — it reflects a level of accreditation methodology rigor no competitor in the DMEPOS consulting space can claim.

Where our competitors specialize by client size (startups, large chains) or accrediting body (ACHC-only, BOC-only), IHS provides independent guidance across all 9 CMS-approved accrediting organizations. We have no financial relationship with any AO. Our accreditor selection recommendation is built entirely on your product mix, state exposure, and risk tolerance — not referral arrangements.

In 2026, the DMEPOS landscape includes five simultaneous crises: the annual survey mandate, the 36-month rule expansion, the enrollment moratorium, the BOC litigation, and the CBP 2028 bid window opening. No competitor has published comprehensive guidance on all five. IHS can advise on all five in a single engagement.

IHS DMEPOS Differentiators

Only independent firm covering the full 2026 regulatory shockwave landscape — annual survey + 36-month rule + moratorium + BOC + CBP 2028
ACHC vs. BOC vs. TCT neutral comparison — no financial relationship with any accrediting organization
BOC controversy navigation for suppliers facing urgent transition decisions
State-level complexity: FL + TX + CA + IL beyond federal accreditation tracked in a single engagement
M&A due diligence under the 36-month rule — expertise at the intersection of accreditation and deal structuring
CBP 2028 preparation — urgency window before Late Summer/Early Fall 2026 bid submission deadline

IHS also serves organizations pursuing Home Health Agency accreditation — adjacent accreditation work often needed when DMEPOS suppliers expand their service lines.

Frequently Asked Questions

Is DMEPOS accreditation required for all suppliers?

Yes — any supplier billing Medicare for DMEPOS items must hold active accreditation from a CMS-approved accrediting organization. 100% of the approximately 8,005 active traditional Medicare DMEPOS supplier locations nationwide hold CMS-recognized accreditation because it is a mandatory condition of Medicare enrollment. (Source: OAMES, January 2024)

How long does DMEPOS accreditation take?

Plan on 4 to 8 months from non-compliant baseline to accreditation award. Post-accreditation PECOS Medicare enrollment adds 50 to 180 additional calendar days — the federal processing mandate is 50 days, but Novitas Solutions backlogs frequently run 3 to 6 months in practice.

What changed with CMS DMEPOS accreditation rules effective January 1, 2026?

Three major changes: (1) surveys now required annually instead of every 36 months; (2) the 36-month ownership transfer rule applies to DMEPOS — majority ownership change triggers immediate Medicare billing termination; (3) the 90-day temporary billing grace period for new branch locations was eliminated. A 6-month enrollment moratorium for DMEPOS medical supply companies also took effect February 27, 2026. (Sources: VGM regulatory update; Hall Render; Benesch Law)

What is the most common reason DMEPOS surveys fail?

Documentation errors are the primary cause of failure in 60% of failed DMEPOS surveys. The single most frequently cited deficiency is Equipment Cleaning and Storage (ACHC DRX7-12D), cited in 30% of ACHC surveys for the fifth consecutive year. (Sources: NikoHealth 2026; ACHC 2025)

What is the current status of BOC as a CMS-approved DMEPOS accreditor?

BOC was reinstated under a federal Temporary Restraining Order on January 9, 2026, after CMS withdrew nationwide approval on December 2, 2025. The May 2025 regional restrictions for California, Florida, New York, and Texas remain in effect. The underlying federal lawsuit is ongoing; the TRO may be modified or lifted pending litigation resolution. IHS recommends against new BOC accreditations in the four restricted states until the litigation resolves.

What happens if I lose DMEPOS accreditation?

Loss of DMEPOS accreditation triggers immediate Medicare billing suspension typically lasting 18 months. Civil monetary penalties for billing Medicare while unaccredited exceed $25,000. During the suspension period, the organization cannot bill Medicare for any covered DMEPOS item. (Source: NikoHealth 2026)

Do pharmacies need separate DMEPOS accreditation?

Pharmacies billing Medicare for DMEPOS products — including diabetic testing supplies, enteral nutrition, and OTS orthotics — must hold DMEPOS supplier accreditation. NABP and ACHC's pharmacy division are frequently used paths for pharmacy-based DMEPOS billing. NABP accreditation covers both pharmacy and certain DMEPOS categories, making it an efficient option for pharmacies with limited DMEPOS billing volume.

What is the 2028 Competitive Bidding Program and why does it matter now?

The DMEPOS Competitive Bidding Program (CBP) 2028 round opens for bid submissions Late Summer/Early Fall 2026. CMS projects awarding approximately 10 national contracts for CGMs and insulin pumps, 8 for urological/ostomy supplies, and 4 for OTS back braces. Only accredited suppliers may submit bids. A supplier that loses accreditation in 2026 is locked out of CBP entirely until the next decade. The CBP compliance window makes 2026 accreditation readiness existential for suppliers in covered categories. [citation needed for CBP contract projections]

Schedule a Gap Analysis

IHS conducts a structured gap assessment of your current documentation, operations, and staff records against your target accrediting organization's standards. You receive a prioritized remediation plan before committing to a full engagement.

Contact IHS: |

Adjacent services: Home Health & Hospice Accreditation